Profil
Before joining IBTM, Ms. Lo was head of Business Development when she worked at Anawrahta Biotech Co. Ltd. and was responsible for product commercialization.
Anawrahta was the first biotech company to conduct stem cell research in Taiwan, focusing on developing cancer vaccines, dendritic cell therapy and monoclonal antibody production.
Anawrahta has close partnerships with Taipei Veterans General Hospital, National Yang-Ming University and the Center of Stem Cell at Taipei Medical University.
Ms. Lo’s involvement in the management at Anawrahta allowed her to have an in-depth knowledge of the biotech industry.
Before joining Anawrahta, she was a researcher at the Cancer Center of Veterans General Hospital where she involved in cancer vaccine development.
She spent a few years at tuberculosis prevention program at the University of Iowa.
She was also an Associated Researcher at Development Center of Biotechnology where she invented pesticide diagnosis kit and involved in biopesticide development.
Aktiva positioner av Min Ching Lo
| Företag | Position | Start |
|---|---|---|
IBT Management Corp.
IBT Management Corp. Investment ManagersFinance IBTM's investment strategy focuses on early- to mid- stage high-tech firms. Their objective is to create growth and create competitive advantage. They seek to maximize returns for their venture capital fund investors and employ a prudent investment strategy. Geographically they concentrate on firms operating in Taiwan, the US, and Europe in segments such as semiconductors, optoelectronics, networking, computers, biotechnology, and software. They typically take minority stakes under 20% in each investee firm. Their investment size ranges from USD 0.3 million to USD 10 million. | Director of Investments | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 1 |
|---|---|
IBT Management Corp.
IBT Management Corp. Investment ManagersFinance IBTM's investment strategy focuses on early- to mid- stage high-tech firms. Their objective is to create growth and create competitive advantage. They seek to maximize returns for their venture capital fund investors and employ a prudent investment strategy. Geographically they concentrate on firms operating in Taiwan, the US, and Europe in segments such as semiconductors, optoelectronics, networking, computers, biotechnology, and software. They typically take minority stakes under 20% in each investee firm. Their investment size ranges from USD 0.3 million to USD 10 million. | Finance |
















